278 related articles for article (PubMed ID: 17576024)
1. Randomised revaccination with pneumococcal polysaccharide or conjugate vaccine in asplenic children previously vaccinated with polysaccharide vaccine.
Smets F; Bourgois A; Vermylen C; Brichard B; Slacmuylders P; Leyman S; Sokal E
Vaccine; 2007 Jul; 25(29):5278-82. PubMed ID: 17576024
[TBL] [Abstract][Full Text] [Related]
2. Safety and immunogenicity of the American Academy of Pediatrics--recommended sequential pneumococcal conjugate and polysaccharide vaccine schedule in pediatric solid organ transplant recipients.
Lin PL; Michaels MG; Green M; Mazariegos GV; Webber SA; Lawrence KS; Iurlano K; Greenberg DP
Pediatrics; 2005 Jul; 116(1):160-7. PubMed ID: 15995047
[TBL] [Abstract][Full Text] [Related]
3. Immunogenicity and safety of a pneumococcal conjugate 7-valent vaccine in infants with sickle cell disease.
Reinert P; Benkerrou M; de Montalembert M; Lesprit E; Abadie I; Bernaudin F; Doit C; Bingen E; Tetelboum R; Bonnet E
Pediatr Infect Dis J; 2007 Dec; 26(12):1105-9. PubMed ID: 18043446
[TBL] [Abstract][Full Text] [Related]
4. Immunogenicity and safety of measles-mumps-rubella, varicella and Haemophilus influenzae type b vaccines administered concurrently with a fourth dose of heptavalent pneumococcal conjugate vaccine compared with the vaccines administered without heptavalent pneumococcal conjugate vaccine.
Black SB; Cimino CO; Hansen J; Lewis E; Ray P; Corsaro B; Graepel J; Laufer D
Pediatr Infect Dis J; 2006 Apr; 25(4):306-11. PubMed ID: 16567981
[TBL] [Abstract][Full Text] [Related]
5. Immunogenicity, safety, and predictors of response after a pneumococcal conjugate and pneumococcal polysaccharide vaccine series in human immunodeficiency virus-infected children receiving highly active antiretroviral therapy.
Abzug MJ; Pelton SI; Song LY; Fenton T; Levin MJ; Nachman SA; Borkowsky W; Rosenblatt HM; Marcinak JF; Dieudonne A; Abrams EJ; Pathak I;
Pediatr Infect Dis J; 2006 Oct; 25(10):920-9. PubMed ID: 17006288
[TBL] [Abstract][Full Text] [Related]
6. Herd immunity and pneumococcal conjugate vaccine: a quantitative model.
Haber M; Barskey A; Baughman W; Barker L; Whitney CG; Shaw KM; Orenstein W; Stephens DS
Vaccine; 2007 Jul; 25(29):5390-8. PubMed ID: 17583392
[TBL] [Abstract][Full Text] [Related]
7. Comparison of pneumococcal conjugate polysaccharide and free polysaccharide vaccines in elderly adults: conjugate vaccine elicits improved antibacterial immune responses and immunological memory.
de Roux A; Schmöle-Thoma B; Siber GR; Hackell JG; Kuhnke A; Ahlers N; Baker SA; Razmpour A; Emini EA; Fernsten PD; Gruber WC; Lockhart S; Burkhardt O; Welte T; Lode HM
Clin Infect Dis; 2008 Apr; 46(7):1015-23. PubMed ID: 18444818
[TBL] [Abstract][Full Text] [Related]
8. Immunologic considerations for the timing of the booster dose of 7-valent pneumococcal conjugate vaccine in young children.
Scheifele DW; Halperin SA; Ochnio JJ; Mozel M; Duarte-Monteiro D; Wortzman D
Pediatr Infect Dis J; 2007 May; 26(5):387-92. PubMed ID: 17468647
[TBL] [Abstract][Full Text] [Related]
9. Emergence of invasive pneumococcal disease caused by nonvaccine serotypes in the era of 7-valent conjugate vaccine.
Muñoz-Almagro C; Jordan I; Gene A; Latorre C; Garcia-Garcia JJ; Pallares R
Clin Infect Dis; 2008 Jan; 46(2):174-82. PubMed ID: 18171247
[TBL] [Abstract][Full Text] [Related]
10. The 23-valent pneumococcal polysaccharide vaccine does not provide additional serotype antibody protection in children who have been primed with two doses of heptavalent pneumococcal conjugate vaccine.
Balmer P; Borrow R; Arkwright PD
Vaccine; 2007 Aug; 25(34):6321-5. PubMed ID: 17629373
[TBL] [Abstract][Full Text] [Related]
11. Immunogenicity of a heptavalent pneumococcal conjugate vaccine in Apache and Navajo Indian, Alaska native, and non-native American children aged <2 years.
Miernyk KM; Parkinson AJ; Rudolph KM; Petersen KM; Bulkow LR; Greenberg DP; Ward JI; Brenneman G; Reid R; Santosham M
Clin Infect Dis; 2000 Jul; 31(1):34-41. PubMed ID: 10913393
[TBL] [Abstract][Full Text] [Related]
12. Immunogenicity and safety of pneumococcal 7-valent conjugate vaccine (diphtheria CRM(197) protein conjugate; Prevenar ) in Korean infants: differences that are found in Asian children.
Kim NH; Lee J; Lee SJ; Lee H; Kim KH; Park SE; Lee HJ
Vaccine; 2007 Nov; 25(45):7858-65. PubMed ID: 17931753
[TBL] [Abstract][Full Text] [Related]
13. Immunogenicity of varying dosages of 7-valent pneumococcal polysaccharide-protein conjugate vaccine in seniors previously vaccinated with 23-valent pneumococcal polysaccharide vaccine.
Jackson LA; Neuzil KM; Nahm MH; Whitney CG; Yu O; Nelson JC; Starkovich PT; Dunstan M; Carste B; Shay DK; Baggs J; Carlone GM
Vaccine; 2007 May; 25(20):4029-37. PubMed ID: 17391816
[TBL] [Abstract][Full Text] [Related]
14. Nasopharyngeal pneumococcal carriage after combined pneumococcal conjugate and polysaccharide vaccination in children with a history of recurrent acute otitis media.
Veenhoven RH; Bogaert D; Schilder AG; Rijkers GT; Uiterwaal CS; Kiezebrink HH; van Kempen MJ; Dhooge IJ; Bruin J; Ijzerman EP; de Groot R; Kuis W; Hermans PW; Sanders EA
Clin Infect Dis; 2004 Oct; 39(7):911-9. PubMed ID: 15472839
[TBL] [Abstract][Full Text] [Related]
15. Pneumococcal conjugate vaccine primes for polysaccharide-inducible IgG2 antibody response in children with recurrent otitis media acuta.
Breukels MA; Rijkers GT; Voorhorst-Ogink MM; Zegers BJ; Sanders LA
J Infect Dis; 1999 May; 179(5):1152-6. PubMed ID: 10191217
[TBL] [Abstract][Full Text] [Related]
16. Protective antibody responses to pneumococcal conjugate vaccine after autologous hematopoietic stem cell transplantation.
Antin JH; Guinan EC; Avigan D; Soiffer RJ; Joyce RM; Martin VJ; Molrine DC
Biol Blood Marrow Transplant; 2005 Mar; 11(3):213-22. PubMed ID: 15744240
[TBL] [Abstract][Full Text] [Related]
17. Total and serotype-specific pneumococcal antibody titres in children with normal and abnormal humoral immunity.
Uddin S; Borrow R; Haeney MR; Moran A; Warrington R; Balmer P; Arkwright PD
Vaccine; 2006 Jul; 24(27-28):5637-44. PubMed ID: 16730399
[TBL] [Abstract][Full Text] [Related]
18. Immunogenicity and safety of 23-valent pneumococcal polysaccharide vaccine as a booster dose in 12- to 18-month-old children primed with 3 doses of 7-valent pneumococcal conjugate vaccine.
Thisyakorn U; Chokephaibulkit K; Kosalaraksa P; Benjaponpitak S; Pancharoen C; Chuenkitmongkol S
Hum Vaccin Immunother; 2014; 10(7):1859-65. PubMed ID: 25424793
[TBL] [Abstract][Full Text] [Related]
19. Pneumococcal bacteremia among infants with fever without known source before and after introduction of pneumococcal conjugate vaccine in the Basque Country of Spain.
Benito-Fernández J; Raso SM; Pocheville-Gurutzeta I; SánchezEtxaniz J; Azcunaga-Santibañez B; Capapé-Zache S
Pediatr Infect Dis J; 2007 Aug; 26(8):667-71. PubMed ID: 17848875
[TBL] [Abstract][Full Text] [Related]
20. Who's calling the shots? Pediatricians' adherence to the 2001-2003 pneumococcal conjugate vaccine-shortage recommendations.
Broder KR; MacNeil A; Malone S; Schwartz B; Baughman AL; Murphy TV; Pickering LK; Moran JS
Pediatrics; 2005 Jun; 115(6):1479-87. PubMed ID: 15930207
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
